ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
8
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,018
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Pure red-cell aplasia and recombinant erythropoietin.
Author(s):
Harvey Luksenburg
,
Timothy R Coté
,
David Braun
,
Andrea S Gershon
Publication date:
2002-05-16
Journal:
The New England journal of medicine
Keywords:
Adverse Drug Reaction Reporting Systems
,
Anemia
,
drug therapy
,
etiology
,
Erythropoietin
,
adverse effects
,
immunology
,
Female
,
Humans
,
Kidney Failure, Chronic
,
complications
,
Male
,
Middle Aged
,
Recombinant Proteins
,
Red-Cell Aplasia, Pure
,
chemically induced
,
United States
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Photoluminescent Nanomaterials
Author and article information
Journal
PubMed ID::
12015400
DOI::
10.1056/NEJM200205163462015
ScienceOpen disciplines:
Chemistry
Keywords:
Adverse Drug Reaction Reporting Systems
,
Anemia
,
drug therapy
,
etiology
,
Erythropoietin
,
adverse effects
,
immunology
,
Female
,
Humans
,
Kidney Failure, Chronic
,
complications
,
Male
,
Middle Aged
,
Recombinant Proteins
,
Red-Cell Aplasia, Pure
,
chemically induced
,
United States
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adverse Drug Reaction Reporting Systems
,
Anemia
,
drug therapy
,
etiology
,
Erythropoietin
,
adverse effects
,
immunology
,
Female
,
Humans
,
Kidney Failure, Chronic
,
complications
,
Male
,
Middle Aged
,
Recombinant Proteins
,
Red-Cell Aplasia, Pure
,
chemically induced
,
United States
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,018
Erythropoietin Does Not Enhance Skeletal Muscle Protein Synthesis Following Exercise in Young and Older Adults
Authors:
Séverine Lamon
,
Evelyn Zacharewicz
,
Emily Arentson-Lantz
…
Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection.
Authors:
J. Camacho
,
F Poveda
,
A Zamorano
…
High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study.
Authors:
Barbara Marinoni
,
Claudia Raineri
,
Rita Campanelli
…
See all similar
Cited by
7
Biosimilar therapeutics—what do we need to consider?
Authors:
Huub Schellekens
Pure red-cell aplasia due to anti-erythropoietin antibodies.
Authors:
Kai-Uwe Eckardt
,
Nicole Casadevall
Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity
Authors:
Shabnam Tangri
,
Bianca Mothé
,
Julie Eisenbraun
…
See all cited by